Day: November 17, 2020

— Funds will support NDA preparatory activities for anticipated filing in 2021 —November 17, 2020, 08:30 AM Eastern Time (press release provided in english only)Rockville, Maryland—ReveraGen, Inc., a privately held company developing vamorolone (VBP15) as a potential safer alternative for corticosteroid treatment in Duchenne muscular dystrophy and other disorders, today announced an award of a $3.3 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) at National Institutes of Health (NIH). The two-year SBIR/STTR Commercialization Readiness Pilot (CRP) Program award will provide additional funding towards the new drug application (NDA) preparation, enabling timely filing after the read-out of the fully-enrolled registration study (VBP15-004; NCT03439670) anticipated in Q2 2021.The Commercialization...

UBISOFT’S ASSASSIN’S CREED VALHALLAIS THE BIGGEST ASSASSIN’S CREED GAME LAUNCH IN HISTORYThe Premiere Next-Gen Title Sold Through More Units in First Week Than Any Other Assassin’s Creed GameBiggest PC Launch Ever for a Ubisoft GameDownload the Press ReleaseParis, France — November 17, 2020 — Today, Ubisoft® announced strong early sales for Assassin’s Creed® Valhalla, one of the highest rated games this season1. Building on favorable review scores and early player response, Assassin’s Creed Valhalla has sold through more units in its first week than any other Assassin’s Creed game sold during the same period.  Assassin’s Creed Valhalla has also become the top-selling Ubisoft PC launch ever, driven by all-time record Ubisoft Store sales performance. With strong feedback from players on next-gen consoles, ACV is delivering on its promise...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.ROUYN-NORANDA, Quebec, Nov. 17, 2020 (GLOBE NEWSWIRE) — Brunswick Resources Inc. (TSX-V: BRU.H) (“Brunswick” or the “Corporation”) and POKO Group Ltd. (“Poko”) are pleased to announce that they have entered into a binding letter of intent (the “LOI”) to complete a business combination transaction (the “Proposed Transaction”) that will result in the reverse take-over of Brunswick by Poko. The entity resulting from the Proposed Transaction (the “Resulting Issuer“) will continue to carry on the business of Poko. The LOI was negotiated at arm’s length and is dated November 16, 2020.Description of PokoPoko is a UK-based CBD company that leverages its strong portfolio of brands,...

The Lens, exclusive to 5G Ultra Wideband customers, transforms the New York Public Library through AR for an experience like no otherWhat you need to know:Verizon and Snap Inc. are launching the first-ever 5G Landmarker Lens, an augmented reality experience exclusively for Verizon 5G Ultra Wideband customers.The 5G Landmarker Lens uses augmented reality to deliver a musical performance from the Grammy®nominated band Black Pumas at the New York Public Library.Experience features the first full-length song ever used in a Snapchat augmented reality Lens, and the virtual performance was shot by Verizon Media’s RYOT in the first and only 5G production studio in the country.NEW YORK, Nov. 17, 2020 (GLOBE NEWSWIRE) — Verizon and Snap Inc. today released the first-ever 5G-enabled Landmarker Lens exclusively for Verizon 5G Ultra Wideband...

Molkom has over 24 years of experience representing pharmaceutical companies in Brazil and over 14 years in Latin America. The company boasts over 45,000 professional contacts worldwide, 5500 plus direct access to buyers and sales and development contracts totaling over $250,000,000 CAD.*Molkom has ability and capacity to grow current sales and distribution networks for Safetest Covid-19 Rapid and other Tests through direct connection to the global biotech marketplaceThis is a critical agreement for Victory Square Health to increase sales of its Safetest Covid-19 Rapid Test products globallyVANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — Victory Square Health Inc. (“VS Health” or the “Company“) – a portfolio company of Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) — is pleased...

 Communiqué FinancierLe Kremlin-Bicêtre, le 17 novembre 2020Le chiffre d’affaires du Groupe confirme la reprise progressive de l’activité malgré une décroissance sur le T3 20203ème trimestreSur 9 moisRépartition par nature d’activité sur 9 mois(1)  Information non auditéeUne tendance à fin septembre moins marquée par l’impact de la crise sanitaireDepuis le mois de juillet, la reprise progressive de l’activité se confirme. Le chiffre d’affaires du 3ème trimestre affiche un retrait de 8,5% par rapport à 2019, contre une baisse de 20,2% du chiffre d’affaires au 2nd trimestre.Sur 9 mois, la France connaît une décroissance de 6,7% de son chiffre d’affaires. Le redémarrage des activités services et le dynamisme des équipes commerciales ont permis d’atténuer en partie les effets de la crise sanitaire.A l’international, le chiffre d’affaires...

NoHo Partners PlcMANAGERS’ TRANSACTIONS 17 November 2020 at 19:30NoHo Partners Plc: Managers’ transactions (Nurminen)In total the disposals reported above are 5,414 shares.Additional information:Jarno Vilponen, CFO, NoHo Partners Plc, tel. +358 40 721 9376Distribution:Nasdaq HelsinkiMajor mediawww.noho.fiNoHo Partners Plc is a Finnish group established in 1996, specialising in restaurant services. The company, which was listed on NASDAQ Helsinki in 2013 and became the first Finnish listed restaurant company, has continued to grow strongly throughout its history. The Group companies include some 250 restaurants in Finland, Denmark and Norway. The well-known restaurant concepts of the company include Elite, Savoy, Teatteri, Yes Yes Yes, Stefan’s Steakhouse, Palace, Löyly, Hanko Sushi, Friends & Brgrs and Cock’s & Cows....

NoHo Partners OyjJOHDON LIIKETOIMET 17.11.2020 klo 19.30NoHo Partners Oyj: Johdon liiketoimet (Nurminen)Yllä ilmoitetut luovutukset ovat yhteensä 5 414 osaketta. Lisätietoja:Jarno Vilponen, talousjohtaja, NoHo Partners Oyj, puh. +358 40 721 9376Jakelu:Nasdaq HelsinkiKeskeiset tiedotusvälineetwww.noho.fiNoHo Partners Oyj on vuonna 1996 perustettu suomalainen ravintola-alan palveluihin erikoistunut konserni. Vuonna 2013 ensimmäisenä suomalaisena ravintolatoimijana NASDAQ Helsinkiin listautunut pörssiyhtiö on kasvanut voimakkaasti koko historiansa ajan. Konsernin yhtiöihin kuuluu noin 250 ravintolaa Suomessa, Tanskassa ja Norjassa. Yhtiön tunnettuja ravintolakonsepteja ovat mm. Elite, Savoy, Teatteri, Yes Yes Yes, Stefan’s Steakhouse, Palace, Löyly, Hanko Sushi, Friends & Brgrs ja Cock’s & Cows. NoHo Partners Oyj:n vuoden...

Communiqué information réglementéeParis, le 17 novembre 2020Mise à disposition du troisième amendement au document d’enregistrement universel 2019 du Groupe BPCELe Groupe BPCE informe que le troisième amendement au document d’enregistrement universel 2019 a été déposé auprès de l’Autorité des Marchés Financiers (AMF) le 17 novembre 2020 sous le n° D. 20-0174-A03.Ce document est tenu gratuitement à la disposition du public dans les conditions prévues par la réglementation en vigueur.Il peut être également consulté à la rubrique « Résultats et publications » de l’espace « Investisseur » du site internet du Groupe BPCEhttps://groupebpce.com/investisseurs/resultats-et-publications/documents-de-reference AttachmentURD2019_Amendement3_Mise_a_disposition

Communiqué information réglementéeParis, le 17 novembre 2020Mise à disposition du troisième amendement au document d’enregistrement universel 2019 du Groupe BPCELe Groupe BPCE informe que le troisième amendement au document d’enregistrement universel 2019 a été déposé auprès de l’Autorité des Marchés Financiers (AMF) le 17 novembre 2020 sous le n° D. 20-0174-A03.Ce document est tenu gratuitement à la disposition du public dans les conditions prévues par la réglementation en vigueur.Il peut être également consulté à la rubrique « Résultats et publications » de l’espace « Investisseur » du site internet du Groupe BPCEhttps://groupebpce.com/investisseurs/resultats-et-publications/documents-de-referencePièce jointeURD2019_Amendement3_Mise_a_disposition